Chinese health experts are raising concerns about the growing interest among parents to use synthetic human growth hormones on their children. Local media outlets cited by The Epoch Times reported ...
DEAR MAYO CLINIC: My 4-year-old hasn't grown much since she was 2. We were told she probably needs growth hormone. She's doing great otherwise. Is it possible she's just going to be very petite? What ...
Sogroya is a long-acting form of somatropin. Somatropin is also called human growth hormone. Sogroya is made by attaching human growth hormone to a small protein that helps it stay in the body longer ...
SINGAPORE, May 29, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the Australian registration of SKYTROFA® (lonapegsomatropin) as a new ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved long-acting once-weekly somatrogon for children with growth hormone deficiency. Somatrogon was ...
(Reuters) -The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc's treatment for growth hormone deficiency in children, the companies said on Wednesday. The ...
Hormones serve as chemical messengers in the body and regulate functions like growth and metabolism. Adrenal hormones affect ...
Strong emotional links between children with chronic conditions and their family caregivers suggest that improving parent well-being may directly benefit a child's overall health and coping mechanisms ...
Parents watch their kid's height charts, count the vegetables, cheer the first steps and first words. Every parent dreams of watching their child grow up healthy, confident and thriving not just in ...
The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...
The rate of growth in children varies with the season while higher latitude and greater summer daylight exposure makes a significant difference in results for children treated with growth hormone, ...
NEW YORK (Reuters Health) - Type 2 diabetes is eight and a half times more common among children in the United States treated with growth hormone than among kids who are not on the hormone treatment, ...